Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P44
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.12% |
| Q3 2025 | 0.19% |
| Q2 2025 | 0.45% |
| Q1 2025 | 0.30% |
| Q4 2024 | 3.29% |
| Q3 2024 | 1.49% |
| Q2 2024 | -1.04% |
| Q1 2024 | 0.56% |
| Q4 2023 | -7.27% |
| Q3 2023 | 27.20% |
| Q2 2023 | 418.25% |
| Q1 2023 | -0.54% |
| Q4 2022 | -0.64% |
| Q3 2022 | -0.66% |
| Q2 2022 | -1.28% |
| Q1 2022 | 0.58% |
| Q4 2021 | -1.39% |
| Q3 2021 | 60.01% |
| Q2 2021 | 2.56% |
| Q1 2021 | -3.86% |
| Q4 2020 | 1.55% |
| Q3 2020 | 2.37% |
| Q2 2020 | -2.81% |
| Q1 2020 | -0.07% |
| Q4 2019 | 2.38% |
| Q3 2019 | -3.19% |
| Q2 2019 | 7.92% |
| Q1 2019 | 24.06% |
| Q4 2018 | -1.92% |
| Q3 2018 | -2.64% |
| Q2 2018 | 14.90% |
| Q1 2018 | -2.95% |
| Q4 2017 | -2.66% |
| Q3 2017 | 4.60% |
| Q2 2017 | 27.19% |
| Q1 2017 | -3.48% |
| Q4 2016 | -11.67% |
| Q3 2016 | 0.14% |
| Q2 2016 | 5.90% |
| Q1 2016 | -2.02% |